The National Institutes of Health is offering grants to small business concerns to support the commercialization of understudied proteins identified in the ‘Illuminating the Druggable Genome’ project (IDG). The project aims to uncover the function of selected understudied proteins in the druggable genome and small businesses are encouraged to validate reagents, data, or experimental approaches. Funding can be used for early research, proof-of-concept demonstrations, assay development/validation, and starting preclinical drug discovery projects. Don’t miss the opportunity as the closing date for applications is Sep 05, 2021.
Opportunity ID: 309854
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-19-033 |
| Funding Opportunity Title: | Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 24, 2018 |
| Last Updated Date: | Oct 24, 2018 |
| Original Closing Date for Applications: | Sep 05, 2021 |
| Current Closing Date for Applications: | Sep 05, 2021 |
| Archive Date: | Oct 11, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The goal of this funding opportunity announcement (FOA) is to solicit applications from small business concerns (SBCs) to initiate early research ultimately leading to the commercialization of understudied proteins identified in the “Illuminating the Druggable Genome” project (IDG; https://commonfund.nih.gov/idg/index ). The purpose of the IDG is to reveal the function of selected understudied proteins in the druggable genome. Organized as a consortium, the project consists of multiple Data and Resource Generation Centers (DRGCs), a Knowledge Management Center (KMC), a Resource Dissemination and Outreach Center (RDOC) and projects developing Cutting Edge Informatics Tools (CEITs). Small businesses are expected to complement the IDG Centers by proposing projects to commercially validate reagents, data or experimental approaches. Projects could range from early proof-of-concept demonstration and assay development/validation to the initiation of preclinical drug discovery projects. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-19-033.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00245838 | Dec 05, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260262 | Dec 05, 2018 | Sep 05, 2021 | View |
Package 1
Mandatory forms
309854 RR_SF424_2_0-2.0.pdf
309854 PHS398_CoverPageSupplement_4_0-4.0.pdf
309854 RR_OtherProjectInfo_1_4-1.4.pdf
309854 PerformanceSite_2_0-2.0.pdf
309854 RR_KeyPersonExpanded_2_0-2.0.pdf
309854 RR_Budget_1_4-1.4.pdf
309854 RR_SubawardBudget30_1_4-1.4.pdf
309854 PHS398_ResearchPlan_4_0-4.0.pdf
309854 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
309854 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
309854 RR_SF424_2_0-2.0.pdf
309854 PHS398_CoverPageSupplement_5_0-5.0.pdf
309854 RR_OtherProjectInfo_1_4-1.4.pdf
309854 PerformanceSite_2_0-2.0.pdf
309854 RR_KeyPersonExpanded_2_0-2.0.pdf
309854 RR_Budget_1_4-1.4.pdf
309854 RR_SubawardBudget30_1_4-1.4.pdf
309854 PHS398_ResearchPlan_4_0-4.0.pdf
309854 SBIR_STTR_Information_1_3-1.3.pdf
309854 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
309854 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
